Mesa Laboratories, Inc.
Mesa Laboratories, Inc. (Nasdaq: MLAB) designs and manufactures life sciences tools and quality-control products and services for regulated pharmaceutical, healthcare, and medical-device applications. Its customers include manufacturers, hospitals, dental offices, clinical research laboratories, contract research… From the company’s description.
Over the twelve months to Jun 30, 2026, Mesa Laboratories, Inc. reported revenue of $249.72M, up 3.0% from a year earlier, and net income of $4.80M. Its operating margin was 9.0%, and operations generated $55.67M in cash. In fiscal 2025, it reported revenue of $249.13M, up 3.4% from fiscal 2024, and net income of $6.71M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Mesa Laboratories, Inc. does
In the company’s own words
Mesa Laboratories, Inc. (Nasdaq: MLAB) designs and manufactures life sciences tools and quality-control products and services for regulated pharmaceutical, healthcare, and medical-device applications. Its customers include manufacturers, hospitals, dental offices, clinical research laboratories, contract research organizations, biopharmaceutical companies, academic laboratories, and dialysis providers. Mesa reports four divisions: Sterilization and Disinfection Control, which supplies biological, chemical, and cleaning indicators and sterility-assurance testing; Clinical Genomics, which sells genetic-analysis instruments, consumables, and services, including its MassARRAY® platform; Biopharmaceutical Development, which provides protein-analysis and peptide-synthesis systems, consumables, and support; and Calibration Solutions, which offers calibration instruments, renal-care meters and consumables, and environmental monitoring systems. Its brands include Apex®, EZTest®, MassARRAY®, Gyrolab®, PurePep®, DialyGuard®, DryCal®, DataTrace®, and ViewPoint®. Mesa’s products and services reach customers through direct sales teams and independent distributors, with manufacturing operations in the United States and Europe. As of March 31, 2026, it had 717 employees. Its website is www.mesalabs.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- LAKEWOOD, CO
- Fiscal year end
- March
- CIK
- 724004
- SIC
- 3823
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Mesa Laboratories, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Mesa Laboratories, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Mesa Laboratories, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Mesa Laboratories, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Mesa Laboratories, Inc.'s last four quarterly filings that the numbers alone won't show?”
